About Nimesh Jaiswal
Nimesh Jaiswal's fervent interest in analyzing and interpreting financial data led him to a career as a financial analyst and journalist. The importance of financial statements in driving a stock’s price is the key approach that he follows while advising investors in his articles.
Nimesh majored in accounting and finance in college and is currently pursuing a CMA (Cost & Management Accountant) program.
Recent Articles By Nimesh Jaiswal
4 Hot Stocks to Add to Your Growth Portfolio
With interest rates remaining at near-zero levels, supportive government policies have been driving the growth prospects of several companies. As such, we think it could be wise to bet on Regeneron (REGN), Energy (ET), Teradata (TDC) and Alkermes (ALKS) because they possess solid growth attributes and have immense upside potential. Read on.
2 Tech Stocks to Buy Hand Over Fist This Month
Increasing demand for advanced technologies in almost every industry as part of a widespread digital transformation, and a low interest rate environment, position the tech industry to generate solid growth. So, we think fundamentally sound tech stocks SS&C (SSNC) and Avid (AVID) should deliver significant returns in the near term.
3 Tech Stocks on the Verge of Major Breakouts
Technology stocks plunged earlier this year due to investors’ rotation to cyclical stocks to capitalize on the economic recovery. But the sector is regaining its momentum on the back of growing demand for advanced technological solutions and the Fed’s decision to leave benchmark interest rates unchanged for now. So, we think the giants in this space—Microsoft (MSFT), Alphabet (GOOGL), and Facebook (FB)—could deliver solid returns in the near term. Read on.
Forget Dogecoin: These Growth Stocks Are a Smarter Bets
Because governments worldwide are expected to eventually crack down on cryptocurrencies—emulating China’s actions, due to concerns over massive energy consumption and illegal activities facilitated by these currencies—Dogecoin’s prospects look bleak. We think investing in growth stocks Pfizer (PFE) and Broadcom (AVGO) could generate better returns. Let’s discuss.
3 Software Stocks Wall Street Believes are Significantly Overvalued
The software industry is booming with continuing digital transformation and remote activities. However, Wall Street analysts believe the shares of MongoDB (MDB), Appian (APPN), and Fastly (FSLY) have hit valuations that are far ahead of their financials and growth prospects. So, we think these stocks are best avoided now. Read on.
3 Recent IPOs Wall Street Predicts Could Rally by 45% or More
A low-interest-rate environment and low-cost options to go public have driven a boom in the U.S. IPO market over the past year. And with rising investor interest in newly listed companies, Wall Street analysts expect recently listed stocks Coinbase (COIN), C3.ai (AI), and Similarweb (SMWB) to deliver solid returns in the near term. So, let’s take a close look at these names.
The 2 Best Pharma Stocks to Buy on Dips
The aging population in much of the world, including the United States, is driving increased demand for healthcare solutions. And continuing innovations therein is why we believe that it could be wise to scoop up shares of well-positioned pharma companies Johnson & Johnson (JNJ) and Pfizer (PFE) on every dip. Read on.
2 International Stocks Under $15 to Diversify Your Portfolio
Amid rising inflation concerns in the United States, it could be wise to invest in quality international stocks to dodge volatility in the domestic stock market by diversifying one’s portfolio. We think low-priced foreign stocks Industrial and Commercial Bank of China (IDCBY) and Compagnie Financière Richemont (CFRUY) could be solid additions to one’s portfolio given their fundamental strength. Let’s discuss.
3 High-Octane Growth Stocks With 35% Upside Potential
The reopening economy and supportive fiscal and monetary policies have been driving the performance of some quality growth stocks despite investors’ sector rotation out of the growth class and other factors that are driving market volatility. Among examples of this are Hologic (HOLX), EchoStar (SATS), and ArcBest (ARCB), which Wall Street analysts expect to deliver solid returns in the near term given their high growth prospects. Thus, we think it could be wise to bet on these stocks now.